Neurocognitive decline in <scp>HIV</scp> patients is associated with ongoing T‐cell activation in the cerebrospinal fluid

Abstract

The CD4/CD8 ratio, the proportion of EM to naïve T cells and the immune activation profile of CD4+ and CD8+ T cells in PB and CSF might be useful parameters to monitor the efficacy of cART and to identify HIV patients at risk of further neurocognitive deterioration.